Modern diagnostics of nonalcoholic fatty liver disease: noninvasive research methods

Nonalcoholic fatty liver disease (NAFLD) is increasingly recognized as the most common cause of chronic liver disease worldwide. NAFLD represents a wide spectrum of conditions, ranging from simple benign steatosis to nonalcoholic steatohepatitis, which sometimes progresses to cirrhosis and hepatocel...

Full description

Bibliographic Details
Published in:	Regulatory Mechanisms in Biosystems
Main Author:	N. M. Palibroda
Format:	Article
Language:	English
Published:	Oles Honchar Dnipro National University 2016-08-01
Subjects:	nonalcoholic steatohepatitis imaging modalities biomarkers of liver steatosis fibrosis
Online Access:	https://medicine.dp.ua/index.php/med/article/view/282

Similar Items

Advances in Noninvasive Biomarkers for Nonalcoholic Fatty Liver Disease
by: Georgiana-Emmanuela Gîlcă-Blanariu, et al.
Published: (2023-10-01)

Practical Diagnosis and Staging of Nonalcoholic Fatty Liver Disease: A Narrative Review
by: Jennifer Gallacher, et al.
Published: (2018-06-01)

Noninvasive serum biomarkers for liver steatosis in nonalcoholic fatty liver disease: Current and future developments
by: Sang Bong Ahn
Published: (2023-02-01)

The role of zinc in the prevention and treatment of nonalcoholic fatty liver disease
by: Mary Barbara, et al.
Published: (2021-09-01)

Proanthocyanidins-Based Synbiotics as a Novel Strategy for Nonalcoholic Fatty Liver Disease (NAFLD) Risk Reduction
by: Wasitha P. D. W. Thilakarathna, et al.
Published: (2024-02-01)

Comparison of liver enzymes level and sonographic findings value with liver biopsy findings in nonalcoholic fatty liver disease patients
by: Mahsa Khodadoostan, et al.
Published: (2016-01-01)

Current Status in Testing for Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH)
by: Hannah K. Drescher, et al.
Published: (2019-08-01)

Acetaminophen-Induced Hepatotoxicity in Obesity and Nonalcoholic Fatty Liver Disease: A Critical Review
by: Karima Begriche, et al.
Published: (2023-01-01)

The Accuracy of Serum Biomarkers in the Diagnosis of Steatosis, Fibrosis, and Inflammation in Patients with Nonalcoholic Fatty Liver Disease in Comparison to a Liver Biopsy
by: Ivana Mikolasevic, et al.
Published: (2022-02-01)

Noninvasive imaging biomarkers for liver fibrosis in nonalcoholic fatty liver disease: current and future
by: Jung Hwan Yu, et al.
Published: (2023-02-01)

Fibroblast Growth Factor-21 as a Potential Therapeutic Target of Nonalcoholic Fatty Liver Disease
by: Raptis DD, et al.
Published: (2023-01-01)

Role of oxidative stress and glutathione system in the pathogenesis of nonalcoholic fatty liver disease
by: T. E. Promenasheva, et al.
Published: (2014-09-01)

Nonalcoholic fatty liver disease
by: Lafaine M. Grant, et al.
Published: (2004-07-01)

ADEMETHIONINE IN THERAPY OF NON-ALCOHOLIC FATTY LIVER DISEASE
by: A. V. Polukhina, et al.
Published: (2017-11-01)

Pharmaceutical Strategies to Improve Druggability of Potential Drug Candidates in Nonalcoholic Fatty Liver Disease Therapy
by: Reeju Amatya, et al.
Published: (2023-07-01)

Noninvasive Evaluation of Nonalcoholic Fatty Liver Disease
by: Dae Ho Lee
Published: (2020-06-01)

The OMICs Window into Nonalcoholic Fatty Liver Disease (NAFLD)
by: Lucia Carulli, et al.
Published: (2019-02-01)

EXPRESSION OF TLR2, TLR3, TLR4 AND PROINFLAMMATORY TNF AND IL-6 CYTOKINES IN LIVER BIOPSIES OF NONALCOHOLIC FATTY LIVER DISEASE PATIENTS
by: A. V. Bogolyubova, et al.
Published: (2019-12-01)

SYSTEMATIC REVIEW WITH COMPARATIVE ANALYSIS OF RECOMMENDATIONS FOR THE DIAGNOSIS OF NONALCOHOLIC FATTY LIVER DISEASE
by: N.A. TOKTOGULOVA
Published: (2021-03-01)

Prediction of course and progression of nonalcoholic fatty liver disease in patients with obesity and pathology of the biliary tract with the help of mathematical modeling.
by: A. Yu. Filippova, et al.
Published: (2017-12-01)

The Epidemiology, Risk Profiling and Diagnostic Challenges of Nonalcoholic Fatty Liver Disease
by: Umair Iqbal, et al.
Published: (2019-03-01)

Nonalcoholic Fatty Liver Disease—A Concise Review of Noninvasive Tests and Biomarkers
by: Tamara Bassal, et al.
Published: (2022-11-01)

Effect of 12-week intermittent calorie restriction compared to standard of care in patients with nonalcoholic fatty liver disease: a randomized controlled trial
by: Han Ah Lee, et al.
Published: (2023-08-01)

Features of eating behavior in children with different forms of non-alcoholic fatty liver disease
by: Yu.M. Stepanov, et al.
Published: (2021-09-01)

Which dietary patterns fend off nonalcoholic fatty liver disease? A systematic review of observational and interventional studies
by: Farnush Bakhshimoghaddam, et al.
Published: (2024-11-01)

Vaspin, resistin, retinol-binding protein-4, interleukin-1α and interleukin-6 in patient with nonalcoholic fatty liver diseas
by: Stergios A. Polyzos, et al.
Published: (2016-09-01)

The role of hepatic macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
by: Ji-Young Cha, et al.
Published: (2018-12-01)

The interplay between nonalcoholic fatty liver disease and atherosclerotic cardiovascular disease
by: Alexandra C. Finney, et al.
Published: (2023-05-01)

Targeting MRG15 for the treatment of nonalcoholic steatohepatitis
by: Yao Zhang, et al.
Published: (2022-12-01)

Features of Glucose Homeostasis and Blood Lipid Spectrum in Patients with Nonalcoholic Fatty Liver Dis ease Depending on the Obesity Degree
by: Korniichuk I., et al.
Published: (2019-04-01)

Nonalcoholic fatty liver disease: The role of quercetin and its therapeutic implications
by: Maria Sotiropoulou, et al.
Published: (2021-01-01)

Noninvasive assessment of nonalcoholic fatty liver disease
by: Gajanan A Rodge, et al.
Published: (2021-01-01)

Multinodular fatty liver after herpes-zoster vaccine: Case report and review of the literature
by: Michael Shim, et al.
Published: (2008-10-01)

Gallstone Disease Does Not Predict Liver Histology in Nonalcoholic Fatty Liver Disease
Published: (2014-05-01)

Potential Therapeutic Application of Estrogen in Gender Disparity of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
by: Chanbin Lee, et al.
Published: (2019-10-01)

CT-based Hounsfield unit values reflect the degree of steatohepatitis in patients with low-grade fatty liver disease
by: Ha Neul Kim, et al.
Published: (2023-03-01)

Exploring serum bile acids as potential noninvasive biomarkers for nonalcoholic fatty liver disease
by: Ashraf Abbass Basuni, et al.
Published: (2024-10-01)

Development of a diagnostic support system for the fibrosis of nonalcoholic fatty liver disease using artificial intelligence and deep learning
by: Noppamate Preechathammawong, et al.
Published: (2024-08-01)

Challenges and opportunities in nonalcoholic steatohepatitis
by: Wang Xiaobo
Published: (2022-08-01)

KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease
Published: (2013-12-01)